Özbalak, M. M. Et Al. 2022. Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience. TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.4 , 254-261.

Özbalak, M. M., Güzel Mastanzade, M., Özlük, Ö., Tiryaki, T. O., Erdem, S., Özbalak, E. P., ... Elverdi, T.(2022). Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience. TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.4, 254-261.

Özbalak, Mustafa Et Al. "Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience," TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.4, 254-261, 2022

Özbalak, Mustafa M. Et Al. "Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience." TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.4, pp.254-261, 2022

Özbalak, M. M. Et Al. (2022) . "Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience." TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.4, pp.254-261.

@article{article, author={Mustafa Murat ÖZBALAK Et Al. }, title={Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2022, pages={254-261} }